JOINTY PLUS GEL
Diclofenac Diethylamine BP 2.32% W/W eq. to Diclofenac Sodium 2.00% W/W Linseed Oil BP 3.00% W/W Methyl salicyclate IP 10.00% W/W Menthol IP 5.00% W/W Benzyl Alcohol IP 1.00% W/W (Preservetive) Gel Base q.s.
| Composition | Diclofenac Diethylamine BP 2.32% W/W eq. to Diclofenac Sodium 2.00% W/W Linseed Oil BP 3.00% W/W Methyl salicyclate IP 10.00% W/W Menthol IP 5.00% W/W Benzyl Alcohol IP 1.00% W/W (Preservetive) Gel Base q.s. |
| Packing | LAMITUBE - 30 GM |
| MRP | ₹127 |
Product Overview
JOINTY PLUS GEL is an advanced topical anti-inflammatory gel formulated to target painful joints and musculoskeletal tissues directly. It features an optimized formulation that ensures high skin penetration and sustained localized therapeutic action.
Indications
This gel is indicated for the rapid alleviation of localized pain associated with:
- Osteoarthritis of peripheral joints and small finger joints.
- Acute soft tissue injuries, including tendonitis, tenosynovitis, and bursitis.
- Post-traumatic muscle strains, ligament sprains, and structural backaches.
Dosage & Administration
Apply a small amount (2g to 4g) of the gel to the affected anatomical zone, rubbing it in gently until absorbed. Apply three to four times daily. Wash hands thoroughly after application unless the hands are the treated zone.
Adverse Effects
Local side effects are typically minor and localized, including contact dermatitis, skin dryness, localized rash, or scaling at the treatment site.
View Complete Medical Information
Contraindications
Contraindicated in patients with a history of systemic hypersensitivity to diclofenac, aspirin, or other non-steroidal anti-inflammatory drugs (NSAIDs) presenting as asthma or urticaria. Do not apply to damaged skin structures.
Warnings & Precautions
Avoid contact with eyes, nasal structures, and oral mucosa. Although systemic absorption is low, caution is advised if the patient has active gastrointestinal ulceration or severe renal insufficiency when applied over extensive tissue surface areas.
Drug Interactions
Concomitant oral NSAID therapy may slightly increase the risk of systemic adverse reactions. Systemic interactions are minimal due to the localized distribution pattern of the active compounds.
Storage Instructions
Store below 30°C. Do not freeze. Keep the tube tightly closed after every usage period.
Request This Product
- WHO-GMP Certified Formulations
- Monopoly Rights Available
- Get bulk pricing & MOQ
+91 9689237122 · replies within hours
Related Products
More products in the ORTHO therapeutic category
LINSEED GEL
Diclofenac Diethylamine BP 2.32% w/w Eq To Diclofenac Sodium 2% w/w Linseed Oil BP 3% w/w Methyl Salicylate IP 10 %w/w Menthol IP 5 % w/wBenzyl alcohol IP (preservative) 1% w/w Gel Base q.s.
LAMINATED TUBE - 30 GM
ROSICIAN TAB [30*1]
Each FIim tablet contains : Boswellia Serrata Extract (65%) 307.5 mg Devils claw extract (20%) 100 mg Rose hip extract 275 mg
WHITE HDPE BOTTLE WITH CARTON - 30*1
ETOCIAN MR
Composition:Each tablet contains: Etoricoxib IP 60 mg Thiocolchicoside IP 8 mg Excipients q.s.
ALU ALU - 10*10 Tablets (ALU-ALU Packing)
Interested in this product?
Contact our team to discuss PCD franchise, bulk orders, or contract manufacturing for your market.